Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.020
+0.030 (1.50%)
At close: Dec 26, 2025
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of $65.71 million as of December 26, 2025. Its market cap has increased by 23.52% in one year.
Market Cap
65.71M
Enterprise Value
77.61M
Revenue
104.10M
Ranking
n/a
PE Ratio
172.47
Stock Price
$2.02
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 30.10M to 65.71M, an increase of 118.29%. That is a compound annual growth rate of 6.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 65.71M | 10.62% |
| Dec 31, 2024 | 59.40M | 29.86% |
| Dec 29, 2023 | 45.74M | 48.80% |
| Dec 30, 2022 | 30.74M | -23.08% |
| Dec 31, 2021 | 39.97M | -48.56% |
| Dec 31, 2020 | 77.70M | 82.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |